Skip to content

An Investigation of the effect of using a conformable and wearable ice pack on pain and discomfort following sacroiliac joint injection.

An Investigation into the efficacy of using a conformable and wearable ice pack on pain and analgesic use following sacroiliac joint injection

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622000554763
Enrollment
80
Registered
2022-04-11
Start date
2022-05-01
Completion date
2023-02-28
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The research project aims to investigate the effect of using a cold pack on any pain felt following an injection to the sacroiliac joint. We are also interested to see if the use of the cold pack changes any need for pain medications.

Interventions

Eligible subjects will be provided with a wearable and conformable gel ice pack to use post injection to the sacroiliac joint The provision of the ice pack and instructions in its use will be provided by the principal investigator, an experienced SEM Physician. The instructions for use will be provided immediatley following the injection and subjects will begin using it at this time. Following 1 hour of use a 30 minute break will be undertaken and then it will be re-applied. The ice pack will be

Eligible subjects will be provided with a wearable and conformable gel ice pack to use post injection to the sacroiliac joint The provision of the ice pack and instructions in its use will be provided by the principal investigator, an experienced SEM Physician. The instructions for use will be provided immediatley following the injection and subjects will begin using it at this time. Following 1 hour of use a 30 minute break will be undertaken and then it will be re-applied. The ice pack will be used in this manner up to 72 hours post injection. It will be removed for sleeping.

Sponsors

Univeristy of Notre Dame Australia
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

over age 18 and with the capacity to provide informed consent Patients undergoing pre-determined sacroiliac joint injection

Exclusion criteria

Inability to understand the Patient Consent and Information Form Prior reaction to the use of cold therapies

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026